Chemotherapy and radiation therapy for breast cancer: What is the optimal sequence?

被引：17

作者：

Bellon, JR ^{[1
]}

Harris, JR

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA

[2] Harvard Univ, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 01期

关键词：

D O I：

10.1200/JCO.2005.09.962

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5 / 7

页数：3

共 24 条

[1] Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy [J].

Assersohn, L ;

Powles, TJ ;

Ashley, S ;

Nash, AG ;

Neal, AJ ;

Sacks, N ;

Chang, J ;

della Rovere, UQ ;

Naziri, N .

ANNALS OF ONCOLOGY, 1999, 10 (12) :1451-1455

[2] Bisphosphonates for metastatic bone disease: a therapeutic rationale [J].

Bell, R .

EJC SUPPLEMENTS, 2004, 2 (05) :1-4

[3] A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma [J].

Bellon, JR ;

Shulman, LN ;

Come, SE ;

Li, XC ;

Gelman, RS ;

Silver, BJ ;

Harris, JR ;

Recht, A .

CANCER, 2004, 100 (07) :1358-1364

[4]

Buchholz TA, 1999, CANCER J, V5, P159

[5] EFFECT OF DELAY IN RADIATION IN THE COMBINED MODALITY TREATMENT OF BREAST-CANCER [J].

BUCHHOLZ, TA ;

AUSTINSEYMOUR, MM ;

MOE, RE ;

ELLIS, GK ;

LIVINGSTON, RB ;

PELTON, JG ;

GRIFFIN, TW .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (01) :23-35

[6] Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy [J].

Buchholz, TA ;

Tucker, SL ;

Erwin, J ;

Mathur, D ;

Strom, EA ;

McNeese, MD ;

Hortobagyi, GN ;

Cristofanilli, M ;

Esteva, FJ ;

Newman, L ;

Singletary, SE ;

Buzdar, AU ;

Hunt, KK .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2240-2246

[7] Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: Eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil [J].

Fisher, B ;

Dignam, J ;

Mamounas, EP ;

Costantino, JP ;

Wickerham, DL ;

Redmond, C ;

Wolmark, N ;

Dimitrov, NV ;

Bowman, DM ;

Glass, AG ;

Atkins, JN ;

Abramson, N ;

Sutherland, CM ;

Aron, BS ;

Margolese, RG .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) :1982-1992

[8]

HARTSELL WF, 1995, CANCER, V76, P2497, DOI 10.1002/1097-0142(19951215)76:12<2497::AID-CNCR2820761214>3.0.CO

[9]

2-6

[10] Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer [J].

Henderson, IC ;

Berry, DA ;

Demetri, GD ;

Cirrincione, CT ;

Goldstein, LJ ;

Martino, S ;

Ingle, JN ;

Cooper, MR ;

Hayes, DF ;

Tkaczuk, KH ;

Fleming, G ;

Holland, JF ;

Duggan, DB ;

Carpenter, JT ;

Frei, E ;

Schilsky, RL ;

Wood, WC ;

Muss, HB ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) :976-983

← 1 2 3 →